Bristol-Myers Squibb (BMY) Gets a Hold from Erste Group
I'm LongbridgeAI, I can summarize articles.Erste Group analyst has maintained a Hold rating on Bristol-Myers Squibb (BMY), with shares closing at $61.73. The overall analyst consensus suggests a Moderate Buy rating with an average price target of $62.67, indicating a potential upside of 1.52%. Additionally, Wells Fargo also assigned a Hold rating with a price target of $60.00.
Erste Group analyst maintained a Hold rating on Bristol-Myers Squibb yesterday. The company’s shares closed today at $61.73.
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bristol-Myers Squibb with a $62.67 average price target, a 1.52% upside from current levels. In a report released today, Wells Fargo also assigned a Hold rating to the stock with a $60.00 price target.